Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
RPRX
ACCE ResearchedRoyalty Pharma plc Class A Ordinary Shares
HealthcareBiotechnologyNASDAQ
$49.47
-1.24%today
MKT CAP
$29.3B
NEXT EARNINGS
May 6
Analysis in progress.
+49.9% · 1Y
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.